Newswise — Fairfax, Va., July 11, 2014 – Members of the American Society for Radiation Oncology (ASTRO) have elected four new officers to serve on its Board of Directors and three members to serve on the Nominating Committee. The new officers will begin their terms at the Annual Business Meeting on Tuesday, September 16, 2014 at 11:30 a.m. Pacific time, at ASTRO’s 56th Annual Meeting at Moscone Center in San Francisco.
The new Board of Directors members are:President-electDavid C. Beyer, MD, FASTRO, Arizona Oncology Services, Scottsdale, Arizona
Clinical Affairs and Quality Council Vice-chairJames A. Hayman, MD, MBA, University of Michigan, Ann Arbor, Michigan
Education Council Vice-chairStephen M. Hahn, MD, FASTRO, University of Pennsylvania, Philadelphia
Government Relations Council Vice-chairSameer R. Keole, MD, Mayo Clinic, Phoenix
“These four individuals bring an extensive amount of valuable experience and knowledge that will significantly impact our work on behalf of cancer patients worldwide,” said Colleen A.F. Lawton, MD, FASTRO, chair of ASTRO’s Board of Directors. “Their expertise in health policy, health services, quality, clinical research, education and government relations are integral elements to ensure ASTRO and radiation oncology continues to adapt to the changing health care environment.”
Dr. Beyer is the medical director of Arizona Oncology Services in Scottsdale, Arizona. He is an active clinician with a primary focus on prostate cancer. He served ASTRO as a member of the Board of Directors (2007 to 2011) as the vice-chair and then the chair of the Health Policy Council; as co-chair of the Best Practices Committee and the Health Policy Committee; and as a member of the CPT/RUC Advisors Workgroup, the Clinical Affairs and Quality Committee and the Nominating Committee. He has represented ASTRO in front of Congress, the Centers for Medicare and Medicaid Services and the Government Accountability Office and to other medical societies and organizations.
Dr. Beyer has spent his entire career at Arizona Oncology Services, joining the practice in 1985. He specializes in prostate brachytherapy, including seed implants and high-dose-rate brachytherapy, as well as intensity modulated radiation therapy and image guided radiation therapy. He has helped develop and build new freestanding clinics and has participated in affiliations with several hospital-based clinics. Dr. Beyer is a member of the Editorial Board of the Journal of Brachytherapy, the official journal of the American Brachytherapy Society.
Dr. Beyer earned his medical degree in 1979 from the University of Arizona College of Medicine in Tucson, Arizona, completed his residency in internal medicine at the University of Arizona Health Sciences Center in 1982, and achieved his residency in radiation oncology at the University of California Los Angeles Center for Health Sciences in Los Angeles in 1985.
Dr. Hayman is a professor of radiation oncology and the associate chair for clinical activities at the University of Michigan in Ann Arbor, Michigan. His clinical interests include thoracic and breast cancers, and skin, ocular and central nervous system malignancies. Dr. Hayman is active in health services research and has served on various local and national committees related to quality of care. He served ASTRO as co-chair of the Practice Accreditation Workgroup; as chair of the Clinical Affairs and Quality Committee; as member and track chair (patient safety) of the Annual Meeting Scientific Committee; and as a member of both the Best of ASTRO Program Committee and the Research Evaluation Committee.
Dr. Hayman joined the University of Michigan in 1996, immediately following his residency. As a radiation oncologist active in health services research, he has been involved in quality of care-related projects with the National Quality Forum, the Cancer Quality Alliance, the National Comprehensive Cancer Network and the American Medical Association Physician Consortium for Performance Improvement. Dr. Hayman is helping to lead a state-wide collaborative quality initiative, the Michigan Radiation Oncology Quality Consortium, supported by Blue Cross/Blue Shield of Michigan.
Dr. Hayman concurrently earned his medical degree and his Master of Business Administration at the University of Chicago in 1991. He completed his residency in radiation oncology at the Joint Center for Radiation Therapy at Harvard Medical School in Boston in 1996. Dr. Hahn is the chair and Henry K. Pancoast Professor in the Department of Radiation Oncology at the University of Pennsylvania in Philadelphia. An active clinician, he is board certified in radiation oncology, medical oncology and internal medicine. Dr. Hahn’s research interests include investigating the tumor microenvironment in a variety of human tumors including brain tumors; the molecular determinants of tumor microenvironment; and the evaluation of proton therapy as a way to improve the therapeutic impact of radiation therapy. He has served ASTRO as a member of the Annual Meeting Scientific Committee, the CME/MOC Committee and the Clinical Affairs and Quality Committee; as chair of the Task Force on Proton Beam Therapy; and as a member of the Radiation Oncology Institute’s (ROI) Board of Trustees and a liaison for ROI’s Research Committee.
Dr. Hahn began his career at the National Cancer Institute (NCI) in Bethesda, Maryland, in 1993. In 1995, he became a medical and radiation oncologist at Redwood Regional Oncology in Santa Rosa, California. He took the role of assistant professor of radiation oncology at the University of Pennsylvania in Philadelphia in 1996, where he currently practices. He has been a faculty member for eight years and is currently a course director of the Flims Course for Clinical Trials Methodology, an educational program that introduces junior clinical oncologists in any oncology subspecialty to the principles of good clinical trial design.
Dr. Hahn earned his medical degree from the Temple School of Medicine in Philadelphia in 1984, and completed his residency in internal medicine at the University of California, San Francisco in 1988, completed a fellowship in medical oncology at NCI in 1991 and achieved his residency in radiation oncology at NCI in 1994.
Dr. Keole is an assistant professor and senior associate consultant of radiation oncology at the Mayo Clinic in Scottsdale, Arizona. His clinical interests include proton therapy, pediatric oncology, central nervous system malignancies, lymphoma, sarcoma, and breast and genitourinary cancers. He served ASTRO as chair of the Government Relations Committee and the ASTRO Political Action Committee; as vice-chair of the Congressional Relations Subcommittee; and as a member of the CPT/RUC Advisors Workgroup, the Code Development and Valuation Subcommittee and the State Captain Initiative.
Dr. Keole began his medical career at the University of Florida in Gainesville, Florida, in 2005. In 2009, he joined Radiation Medicine Associates, a private practice group in Oklahoma City. He moved to the Mayo Clinic in 2012, where he leads the Proton Beam Therapy Program. He has served as a member of the Pediatric Proton Foundation’s Board of Directors since 2009.
Dr. Keole earned his medical degree at the Ross University School of Medicine in Roseau, Dominica in 1999. He completed his radiation oncology residency at the Wayne State University School of Medicine in Detroit in 2004.
ASTRO’s Nominating Committee is responsible for preparing a slate of nominees for each elective position of ASTRO to be filled that year. The committee consists of 12 members: the immediate past chair of the Board of Directors, the five Council chairs and six elected members that are not currently serving on ASTRO’s Board of Directors. The six elected members serve staggered three-year terms. Three elected positions on the Nominating Committee were filled by election this year. The new Nominating Committee members are:Nominating Committee Academic PhysicianWilliam M. Mendenhall, MD, University of Florida, Gainesville, Florida
Nominating Committee Community Practice PhysicianPatricia Hardenbergh, MD, Shaw Regional Cancer Center, Edwards, Colorado
Nominating Committee RadiobiologistKathryn Held, PhD, Massachusetts General Hospital, Boston
For more information about ASTRO’s 56th Annual Meeting, visit www.astro.org/AnnualMeeting.
For press registration and media policies for ASTRO’s 56th Annual Meeting, visit www.astro.org/AMpress.
ABOUT ASTRO ASTRO is the premier radiation oncology society in the world, with more than 10,000 members who are physicians, nurses, biologist, physicists, radiation therapists, dosimetrists and other health care professionals that specialize in treating patients with radiation therapies. As the leading organization in radiation oncology, the Society is dedicated to improving patient care through professional education and training, support for clinical practice and health policy standards, advancement of science and research, and advocacy. ASTRO publishes two medical journals, International Journal of Radiation Oncology, Biology, Physics (www.redjournal.org) and Practical Radiation Oncology (www.practicalradonc.org); developed and maintains an extensive patient website, www.rtanswers.org; and created the Radiation Oncology Institute (www.roinstitute.org), a non-profit foundation to support research and education efforts around the world that enhance and confirm the critical role of radiation therapy in improving cancer treatment. To learn more about ASTRO, visit www.astro.org.###